Cancer's power harnessed — lymphoma mutations supercharge T cells
In this episode:0:46 Borrowing tricks from cancer could help improve immunotherapyT cell based immunotherapies have revolutionised the treatment of certain types of cancer. However these therapies — which involved taking someone’s own T cells and reprogramming them to kill cancer cells — have struggled to treat solid tumours, which put up multiple defences. To overcome these, a team has taken mutations found in cancer cells that help them thrive and put them into therapeutic T cells. Their results show these powered-up cells are more efficient at targeting solid tumours, but don’t turn cancerous themselves.Research...
Source: Nature Podcast - February 7, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma
A new trial from Italy challenges a decades-old assumption that autologous stem cell transplant is more effective than radioimmunotherapy for consolidation after follicular lymphoma relapse. (Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - December 5, 2023 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts
JAMA Cardiology : Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD. Related Content: Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 29, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 27, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns
Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL) (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 7, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
CAR T-cell therapy for people with diffuse large B-cell lymphoma which returns after treatment or no longer responds to treatment
Diffuse large B-cell lymphoma is a fast-growing cancer of the lymphatic system. A new Cochrane Review from September 2021 looks at the evidence on the effects of one treatment, chimeric antigen receptor (CAR) T-cell therapy for people whose disease relapses or does not respond to other treatments. We asked the lead author, Moritz Ernst from the Faculty of Medicine and University Hospital Cologne in Germany to tell us what they found. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 29, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
Lymphoma - What is the role of diagnostic testingcytogenetics in 2016
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Lymphoma - Is there still a role for chemo
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Lymphoma - What is the role of diagnostic testingcytogenetics in 2016
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016
Author: cancergrace
Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts
Lymphoma - Is there still a role for chemo
Author: cancergrace
Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Earn CME: <a target='_blank' href='https://naccme.com/program/7334'>https://naccme.com/program/...</a><br /><br />In this presentation from the 'Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas' symposium at the 2019 Great Debates & Updates in Hematologic M...
Author: imedex
Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts
